Michael Byrnes
2023 - eFFECTOR Therapeutics
In 2023, Michael Byrnes earned a total compensation of $826.6K as Chief Financial Officer at eFFECTOR Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,000 |
|---|---|
| Option Awards | $171,776 |
| Salary | $450,000 |
| Other | $33,817 |
| Total | $826,593 |
Byrnes received $450K in salary, accounting for 54% of the total pay in 2023.
Byrnes also received $171K in non-equity incentive plan, $171.8K in option awards and $33.8K in other compensation.
Rankings
In 2023, Michael Byrnes' compensation ranked 1,423rd out of 3,006 executives tracked by ExecPay. In other words, Byrnes earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,423 out of 3,006 | 53rd |
Division Manufacturing | 847 out of 1,650 | 49th |
Major group Chemicals And Allied Products | 555 out of 918 | 40th |
Industry group Drugs | 542 out of 881 | 39th |
Industry Pharmaceutical Preparations | 380 out of 637 | 40th |
Source: SEC filing on April 26, 2024.
Byrnes' colleagues
We found two more compensation records of executives who worked with Michael Byrnes at eFFECTOR Therapeutics in 2023.